Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chad K Porter

Showing results (121-130 of 127) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 127 results.
Iscience|September 28, 2022
Asymptomatic or symptomatic SARS-CoV-2 infection plus vaccination confers increased adaptive immunity to variants of concernPeifang Sun, Irene Ramos, Camila H Coelho, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2026
Human enterotoxigenic <i>Escherichia coli</i> (ETEC) infections elicit antibodies that broadly neutralize mucinases of pathogenic <i>Escherichia coli</i> and <i>Shigella</i>David P Buckley, Marjahan Akhtar, Mahima Thapa, et al.
Microbiology Spectrum|November 14, 2022
Serum Fc-Mediated Monocyte Phagocytosis Activity Is Stable for Several Months after SARS-CoV-2 Asymptomatic and Mildly Symptomatic InfectionSindhu Vangeti, Sivakumar Periasamy, Peifang Sun, et al.
Gastroenterology|January 12, 2023
Anti-Integrin αvβ6 Autoantibodies Are a Novel Biomarker That Antedate Ulcerative ColitisAlexandra E Livanos, Alexandra Dunn, Jeremy Fischer, et al.
The Lancet. Respiratory Medicine|May 8, 2021
Viable virus shedding during SARS-CoV-2 reinfectionAndrew G Letizia, Darci R Smith, Yongchao Ge, et al.
The Lancet. Respiratory Medicine|April 18, 2021
SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort studyAndrew G Letizia, Yongchao Ge, Sindhu Vangeti, et al.
Epidemiology (Cambridge, Mass.)|August 9, 2022
SARS-CoV-2 Outbreak Dynamics in an Isolated US Military Recruit Training Center With Rigorous Prevention MeasuresRhonda A Lizewski, Rachel S G Sealfon, Sang Woo Park, et al.
Pageof 13

Showing results (121-130 of 127) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
Iscience|September 28, 2022
Asymptomatic or symptomatic SARS-CoV-2 infection plus vaccination confers increased adaptive immunity to variants of concernPeifang Sun, Irene Ramos, Camila H Coelho, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2026
Human enterotoxigenic <i>Escherichia coli</i> (ETEC) infections elicit antibodies that broadly neutralize mucinases of pathogenic <i>Escherichia coli</i> and <i>Shigella</i>David P Buckley, Marjahan Akhtar, Mahima Thapa, et al.
Microbiology Spectrum|November 14, 2022
Serum Fc-Mediated Monocyte Phagocytosis Activity Is Stable for Several Months after SARS-CoV-2 Asymptomatic and Mildly Symptomatic InfectionSindhu Vangeti, Sivakumar Periasamy, Peifang Sun, et al.
Gastroenterology|January 12, 2023
Anti-Integrin αvβ6 Autoantibodies Are a Novel Biomarker That Antedate Ulcerative ColitisAlexandra E Livanos, Alexandra Dunn, Jeremy Fischer, et al.
The Lancet. Respiratory Medicine|May 8, 2021
Viable virus shedding during SARS-CoV-2 reinfectionAndrew G Letizia, Darci R Smith, Yongchao Ge, et al.
The Lancet. Respiratory Medicine|April 18, 2021
SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort studyAndrew G Letizia, Yongchao Ge, Sindhu Vangeti, et al.
Epidemiology (Cambridge, Mass.)|August 9, 2022
SARS-CoV-2 Outbreak Dynamics in an Isolated US Military Recruit Training Center With Rigorous Prevention MeasuresRhonda A Lizewski, Rachel S G Sealfon, Sang Woo Park, et al.
Pageof 13